BCAX in the 13F filings
Bicara Therapeutics Inc · CUSIP 055477103
- Quarter end
- 30 Jun 2026
- the date the book describes
- Filed
- 2 Sep 2026
- latest of these filings; the earliest 3 Aug 2026
- Managers listing it
- 13
- at least, of 95 tracked, among listed positions
- Comparable managers
- 91
- filed both Q1 2026 and Q2 2026; 1 listed it in both
- Shares listed
- 8,806,740
- combined, among listed positions
- Reported value
- $261m
- combined, at the quarter end
AllianceBernstein LP. Values in this filing are at the previous quarter end's prices; its share count is the quarter end's.
Among the 91 comparable managers: 7 buyers (opened or added shares) and 8 sellers (trimmed or exited), at least, among listed positions. Their net change in shares was -887,052.
Managers listing BCAX in Q2 2026
13 of 13 holders
Largest increases and reductions, by shares
Increases
- T. Rowe Price Associates Incexisting position · 1,904,248 shares now+528,050
- Walleye Capital LLCexisting position · 353,226 shares now+245,218
- D. E. Shaw & Co.existing position · 498,193 shares now+221,250
- Millennium Management LLCexisting position · 262,254 shares now+105,552
- AllianceBernstein LPexisting position · 55,990 shares now+24,160
Reductions
- Citadel Advisors LLCexisting position · 211,142 shares now-1,448,200
- Fidelity (FMR LLC)existing position · 1,893,070 shares now-207,859
- Janus Henderson Group Ltdexisting position · 3,171,015 shares now-168,203
- Hudson Bay Capital Management LPexisting position · 105,000 shares now-128,703
- Two Sigma Investments LPexisting position · 46,606 shares now-43,275
New positions and exits
New (0)
No new position among listed positions.
Exited (3)
- Balyasny Asset Management LLCwas $434k
- Susquehanna International Group LLPwas $218k
- Squarepoint Ops LLCwas $214k
Ownership over time
Tracked managers listing it, at least.
| Quarter | Holders | Reported value | Buyers | Sellers |
|---|---|---|---|---|
| Q3 2024 | 4 | $38m | 4 | 0 |
| Q4 2024 | 1 | $4.8m | 0 | 3 |
| Q2 2025 | 1 | $3.7m | 1 | 0 |
| Q3 2025 | 1 | $8.0m | 1 | 1 |
| Q4 2025 | 1 | $44m | 11 | 8 |
| Q1 2026 | 1 | $66m | 10 | 8 |
| Q2 2026 | 2 | $104m | 7 | 8 |
Compare with…
Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.
BCAX and LLY →BCAX and TMO →BCAX and JNJ →Choose a stock to compare with BCAX →
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.
Which funds own BCAX, latest filings →Back to the 13F Explorer →